S C Tentoni|K A High - JoVE Visualize

Showing results (31-40 of 69) with videos related to

Pageof 7

Sort By:

Blood|January 1, 1997

Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoterA A Arbini, E S Pollak, J K Bayleran, et al.

Cell and Tissue Kinetics|January 1, 1989

Flow cytometric correlation of the c-myc oncoprotein and cell cycle kinetics of HL60 leukaemia during induced maturation with cytosine arabinoside and dimethylsulphoxideG A Dent, L H Ayscue, K A High, et al.

The Journal of Clinical Investigation|November 1, 1991

Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretionH H Watzke, A Wallmark, N Hamaguchi, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989

Canine hemophilia B resulting from a point mutation with unusual consequencesJ P Evans, K M Brinkhous, G D Brayer, et al.

Blood|February 15, 1989

Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptideM N Huang, C K Kasper, H R Roberts, et al.

Blood|July 1, 1989

Molecular cloning of a cDNA encoding canine factor IXJ P Evans, H H Watzke, J L Ware, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001

Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutationR W Herzog, J D Mount, V R Arruda, et al.

Blood|February 13, 2001

Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factorsH L Hung, E S Pollak, R D Kudaravalli, et al.

Nature Genetics|May 1, 1995

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia AL Bi, A M Lawler, S E Antonarakis, et al.

The Journal of Pediatrics|December 8, 1998

Prevalence of the factor V leiden mutation in children and neonates with thromboembolic diseaseJ N Hagstrom, J Walter, R Bluebond-Langner, et al.

Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:

Pageof 7

Blood|January 1, 1997

Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoterA A Arbini, E S Pollak, J K Bayleran, et al.

Cell and Tissue Kinetics|January 1, 1989

Flow cytometric correlation of the c-myc oncoprotein and cell cycle kinetics of HL60 leukaemia during induced maturation with cytosine arabinoside and dimethylsulphoxideG A Dent, L H Ayscue, K A High, et al.

The Journal of Clinical Investigation|November 1, 1991

Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretionH H Watzke, A Wallmark, N Hamaguchi, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989

Canine hemophilia B resulting from a point mutation with unusual consequencesJ P Evans, K M Brinkhous, G D Brayer, et al.

Blood|February 15, 1989

Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptideM N Huang, C K Kasper, H R Roberts, et al.

Blood|July 1, 1989

Molecular cloning of a cDNA encoding canine factor IXJ P Evans, H H Watzke, J L Ware, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001

Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutationR W Herzog, J D Mount, V R Arruda, et al.

Blood|February 13, 2001

Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factorsH L Hung, E S Pollak, R D Kudaravalli, et al.

Nature Genetics|May 1, 1995

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia AL Bi, A M Lawler, S E Antonarakis, et al.

The Journal of Pediatrics|December 8, 1998

Prevalence of the factor V leiden mutation in children and neonates with thromboembolic diseaseJ N Hagstrom, J Walter, R Bluebond-Langner, et al.

Pageof 7